Market research
ACCD Accolade Inc
Current ticker: ACCD
NASDAQ USD Healthcare
Latest close
As of 08 Apr 2025
Test a moving-average rule with historical data.
Market facts
- Market cap
- 576M
- P/E ratio
- Not available
- Analyst target
- 7.03
- Dividend yield
- Not available
- Beta
- 2.1
Profile
Instrument facts
- Exchange
- NASDAQ
- Currency
- USD
- Sector
- Healthcare
- Industry
- Health Information Services
- ISIN
- Not available
- Market cap
- 576M
- P/E ratio
- Not available
- Analyst target
- 7.03
- Dividend yield
- Not available
- Beta
- 2.1
About
About Accolade Inc
Accolade, Inc., together with its subsidiaries, engages in the development and provision of personalized and technology-enabled solutions that help people to understand, navigate, and utilize the healthcare system and their workplace benefits in the United States. The company offers a platform with cloud-based intelligent technology and multimodal support from a team of advocates and clinicians, including registered nurses, physician medical directors, pharmacists, behavioral health specialists, women's health specialists, case management specialists, expert medical opinion providers, and primary care physicians. It also provides medical opinion services to commercial customers; and navigation, care, and advocacy solutions. In addition, the company offers medical consultations that connect patients to qualified condition-specific specialists for adult and pediatric care; and primary care and mental health support solutions. It serves employers who provide employees and their families a single place to turn for their health, healthcare, and benefits needs. The company was incorporated in 2007 and is headquartered in Seattle, Washington.
Research context
Accolade Inc appears in PyInvesting’s US Stock catalogue. The price history above describes this recorded instrument; it does not by itself identify a company’s business or establish a continuous investment return.
- Currency
- USD
- Sector
- Healthcare
- Industry
- Health Information Services
These are the latest stored catalogue classifications, not a historical classification snapshot. An issuer description, classification effective date or currency may be unavailable. Check the issuer’s own disclosures and the observation dates before using these fields for research.
Review backtest assumptions and evidence before treating a chart or stored history as a research result.
Community
Investor discussion
1 comment
Sign in to join the ACCD discussion.
5 years, 6 months ago
Accolade, Inc is currently in a long term uptrend where the price is trading 15.5% above its 200 day moving average.
From a valuation standpoint, the stock is 98.8% cheaper than other stocks from the Healthcare sector with a price to sales ratio of 16.6.
Based on the above factors, Accolade, Inc gets an overall score of 2/5.